NASDAQ:AUTL
Autolus Therapeutics plc Stock News
$4.50
-0.0300 (-0.662%)
At Close: Jun 14, 2024
Autolus Therapeutics Ltd - (NASDAQ:AUTL) Forecasted to Post Q1 2020 Earnings of ($0.70) Per Share
06:42am, Saturday, 07'th Mar 2020
Autolus Therapeutics Ltd – (NASDAQ:AUTL) – Equities research analysts at William Blair upped their Q1 2020 earnings per share (EPS) estimates for Autolus Therapeutics in a note issued to investors
Gilead Sciences (NASDAQ:GILD) & Autolus Therapeutics (NASDAQ:AUTL) Financial Review
11:26am, Friday, 06'th Mar 2020
Gilead Sciences (NASDAQ:GILD) and Autolus Therapeutics (NASDAQ:AUTL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analys
William Blair Weighs in on Autolus Therapeutics Ltd -'s Q1 2021 Earnings (NASDAQ:AUTL)
09:46am, Friday, 06'th Mar 2020
Autolus Therapeutics Ltd – (NASDAQ:AUTL) – Research analysts at William Blair issued their Q1 2021 earnings per share (EPS) estimates for Autolus Therapeutics in a research report issued to client
BRIEF-Molmed Signs Agreement With Autolus Therapeutics
06:42am, Friday, 06'th Mar 2020
Autolus Therapeutics PLC:
Autolus Therapeutics Plc (AUTL) QEarnings Call Transcript
10:01am, Thursday, 05'th Mar 2020
AUTL earnings call for the period ending December 31, 2019.
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Acceleron Pharma (XLRN)
12:08pm, Wednesday, 04'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cytokinetics (CYTK), Acceleron Pharma (XLRN) and Autolus
Autolus Therapeutics (AUTL) CEO Christian Itin on Q4 2019 Results - Earnings Call Transcript
07:38pm, Tuesday, 03'rd Mar 2020
Autolus Therapeutics (NASDAQ:AUTL) Q4 2019 Earnings Conference Call March 03, 2020, 08:30 ET Company Participants Lucinda Crabtree - VP, IR Christian Itin - Cha
BRIEF-Autolus Therapeutics PLC FY Loss Per Share $2.88
03:15pm, Tuesday, 03'rd Mar 2020
Autolus Therapeutics PLC:
The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More
12:51pm, Tuesday, 03'rd Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 2) * Forty Seven Inc (NASDAQ: FTSV)( announced a dea
BRIEF-Autolus Therapeutics Reports Qtrly Loss Per Share $2.88
12:39pm, Tuesday, 03'rd Mar 2020
Autolus Therapeutics PLC:
Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress
12:07pm, Tuesday, 03'rd Mar 2020
- Conference call to be held on March 3, 2020 at 8:30 am EST/1:30 pm GMT - LONDON, March 03, 2020 -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage.
Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress
12:07pm, Tuesday, 03'rd Mar 2020
- Conference call to be held on March 3, 2020 at 8:30 am EST/1:30 pm GMT - LONDON, March 03, 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics...
Did Changing Sentiment Drive Autolus Therapeutics’s (NASDAQ:AUTL) Share Price Down A Worrying 70%?
06:47pm, Monday, 02'nd Mar 2020
The nature of investing is that you win some, and you lose some. And there's no doubt that Autolus Therapeutics plc...
Autolus Therapeutics (AUTL) Set to Announce Earnings on Tuesday
06:52am, Sunday, 01'st Mar 2020
Autolus Therapeutics (NASDAQ:AUTL) will be posting its quarterly earnings results before the market opens on Tuesday, March 3rd. Analysts expect Autolus Therapeutics to post earnings of ($0.71) per sh
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
07:52pm, Saturday, 29'th Feb 2020
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 epidemic will likely drag global growth, the viral outbreak proved ad
